Search research articles
Contact Us
Filters
Showing results (171-180 of 254) with videos related to
Page
of 26
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 5, 2009
Adherence to antiparkinson medication in a multicenter European study
Donald Grosset, Angelo Antonini, Margherita Canesi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 4, 2010
The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire
K Ray Chaudhuri, Cristina Prieto-Jurcynska, Yogini Naidu, et al.
Nature Medicine
|
April 15, 2024
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease
Gennaro Pagano, Kirsten I Taylor, Judith Anzures Cabrera, et al.
Clinical EEG and Neuroscience
|
November 22, 2022
What a Single Electroencephalographic (EEG) Channel Can Tell us About Alzheimer's Disease Patients With Mild Cognitive Impairment
Claudio Del Percio, Susanna Lopez, Giuseppe Noce, et al.
Current Alzheimer Research
|
October 29, 2021
Classification of Patients with Alzheimer's Disease and Dementia with Lewy Bodies using Resting EEG Selected Features at Sensor and Source Levels: A Proof-of-Concept Study
Rodrigo San-Martin, Francisco J Fraga, Claudio Del Percio, et al.
Nature Medicine
|
October 8, 2024
Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial
Gennaro Pagano, Annabelle Monnet, Adriana Reyes, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
January 12, 2021
Stacked autoencoders as new models for an accurate Alzheimer's disease classification support using resting-state EEG and MRI measurements
Raffaele Ferri, Claudio Babiloni, Vania Karami, et al.
Psychophysiology
|
August 30, 2021
Are there consistent abnormalities in event-related EEG oscillations in patients with Alzheimer's disease compared to other diseases belonging to dementia?
Bahar Güntekin, Tuba Aktürk, Xianghong Arakaki, et al.
Parkinsonism & Related Disorders
|
January 11, 2025
A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data
Tania Nikolcheva, Gennaro Pagano, Nathalie Pross, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
|
May 19, 2022
Treatment effects on event-related EEG potentials and oscillations in Alzheimer's disease
Görsev Yener, Duygu Hünerli-Gündüz, Ebru Yıldırım, et al.
Page
of 26
Search research articles
Search
Showing results (171-180 of 254) with videos related to
Sort By:
Page
of 26
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 5, 2009
Adherence to antiparkinson medication in a multicenter European study
Donald Grosset, Angelo Antonini, Margherita Canesi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 4, 2010
The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire
K Ray Chaudhuri, Cristina Prieto-Jurcynska, Yogini Naidu, et al.
Nature Medicine
|
April 15, 2024
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease
Gennaro Pagano, Kirsten I Taylor, Judith Anzures Cabrera, et al.
Clinical EEG and Neuroscience
|
November 22, 2022
What a Single Electroencephalographic (EEG) Channel Can Tell us About Alzheimer's Disease Patients With Mild Cognitive Impairment
Claudio Del Percio, Susanna Lopez, Giuseppe Noce, et al.
Current Alzheimer Research
|
October 29, 2021
Classification of Patients with Alzheimer's Disease and Dementia with Lewy Bodies using Resting EEG Selected Features at Sensor and Source Levels: A Proof-of-Concept Study
Rodrigo San-Martin, Francisco J Fraga, Claudio Del Percio, et al.
Nature Medicine
|
October 8, 2024
Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial
Gennaro Pagano, Annabelle Monnet, Adriana Reyes, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
January 12, 2021
Stacked autoencoders as new models for an accurate Alzheimer's disease classification support using resting-state EEG and MRI measurements
Raffaele Ferri, Claudio Babiloni, Vania Karami, et al.
Psychophysiology
|
August 30, 2021
Are there consistent abnormalities in event-related EEG oscillations in patients with Alzheimer's disease compared to other diseases belonging to dementia?
Bahar Güntekin, Tuba Aktürk, Xianghong Arakaki, et al.
Parkinsonism & Related Disorders
|
January 11, 2025
A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data
Tania Nikolcheva, Gennaro Pagano, Nathalie Pross, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
|
May 19, 2022
Treatment effects on event-related EEG potentials and oscillations in Alzheimer's disease
Görsev Yener, Duygu Hünerli-Gündüz, Ebru Yıldırım, et al.
Page
of 26